Atlas Trials

Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole

Clinical trial NCT01509053 · TERMINATED

Trial details

NCT number
NCT01509053
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2012-01-01
Primary completion
2012-10-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.